We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Diagnostics

Image: Personalized support increased BRCA testing uptake among at-risk relatives from 51% to 73% at six months, reaching 90% by 18 months (Image Credit: Adobe Stock)

Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families

New data show that facilitated family testing increases hereditary cancer testing uptake to 73–90%. More...
05 Oct 2026
Image: The test measures tumor-derived RNA in urine, capturing not only the presence of cancer but also which genes the tumor is actively using. (Image Credit: Shutterstock)

Urine-Based RNA Improves Bladder Cancer Detection and Monitoring

A new urine RNA test detects bladder cancer with 95% sensitivity and 90% specificity and predicts treatment response. More...
02 Oct 2026
Image: A set of 31 tiny RNA markers (small noncoding RNAs) could help identify people at higher lung cancer risk before the disease is clinically detected (Image Credit: 123RF)

Blood RNA Panel Predicts Lung Cancer Risk Years Before Diagnosis

An RNA-based blood panel flags lung cancer risk up to 10 years before diagnosis with 95% accuracy More...
01 Oct 2026
Image: Schematic overview of the obtained results. (Carla Rojo, María Rullan, Miguel Sogbe, et al. eGastroenterology, 2026. doi:10.1136/ egastro-2026-100425)

Bile DNA Testing Detects Tumor Signals Before Conventional Cancer Diagnosis

New data show that bile-based DNA analysis detects cancer in biliary strictures and is more specific than a standard blood marker. More...
01 Oct 2026
Image Credit: iStock

New Blood Test Could Help Predict Severe Scoliosis in Adolescents

A new microRNA blood test predicts progression risk in adolescent idiopathic scoliosis. More...
01 Oct 2026
Image: Developed and manufactured by Freenome and exclusively commercialized by Abbott, SimpleScreen CRC joins the Cologuard Plus test in Abbott’s screening portfolio, which now spans both stool‑ and blood‑based options (Photo courtesy of Freenome)

Blood-Based Test Broadens Colorectal Cancer Screening Options

An FDA-approved blood-based test detects colorectal cancer with 81% sensitivity and 90% specificity More...
01 Oct 2026
Image: Congenital cytomegalovirus can go unnoticed at birth despite later risks to hearing and development (Image Credit: 123RF)

Pooled Saliva PCR Screening Identifies Congenital CMV Missed by Targeted Testing

A pooled saliva PCR method expands newborn cCMV screening, cuts tests 83% and detects cases missed by targeted approaches. More...
30 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Gold Member
Platelet Function Analyzer
PL-12
Electrolyte Analyzer
BKE-B


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.